Pfizer seeks COVID vaccine authorization for 12-15 yr olds in US

COVID-19 vaccine
A clinical assistant prepares a dose of a COVID-19 vaccine to be administered to a affected person. Credit score: Public area symbol courtesy of Lisa Ferdinando, U.S. Division of Protection

Pfizer-BioNTech requested for authorization Friday to make use of their COVID-19 vaccine on 12-15 yr olds in the USA.

The corporations stated in a observation that they plan to make equivalent requests of alternative regulatory government international in coming days.

Their request to the Meals and Drug Management in america comes after Section 3 medical trials of the Pfizer in 12-15 yr olds have been 100 percent efficient in keeping off the illness, consistent with the firms.

In overdue March they revealed the result of trials performed with 2,260 teens in america who the firms stated confirmed “tough anti-body responses.”

The vaccine used to be “neatly tolerated with normally in step with the ones seen in individuals 16 to twenty-five years of age,” the firms stated Friday.

For now the vaccine has emergency authorization to be used in other people 16 and older.

Kids are much less more likely to expand serious COVID so vaccinating them has been much less of a concern than growing older other people inoculated.

The BioNTech/Pfizer shot is in keeping with novel mRNA era and used to be the primary COVID-19 vaccine to be licensed within the West overdue final yr.


Follow the latest news on the coronavirus (COVID-19) outbreak


© 2021 AFP

Quotation:
Pfizer seeks COVID vaccine authorization for 12-15 yr olds in US (2021, April 9)
retrieved 9 April 2021
from https://medicalxpress.com/information/2021-04-pfizer-covid-vaccine-authorization-.html

This report is matter to copyright. Excluding any honest dealing for the aim of personal learn about or analysis, no
section is also reproduced with out the written permission. The content material is supplied for info functions best.

Leave a Reply

Your email address will not be published. Required fields are marked *